- Home
- LTBR vs HRTX Comparison
LTBR vs HRTX Comparison
Compare LTBR & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- HRTX
- Stock Information
- Founded
- LTBR 1992
- HRTX 1983
- Country
- LTBR United States
- HRTX United States
- Employees
- LTBR N/A
- HRTX N/A
- Industry
- LTBR Professional Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- HRTX Health Care
- Exchange
- LTBR Nasdaq
- HRTX Nasdaq
- Market Cap
- LTBR 397.8M
- HRTX 276.1M
- IPO Year
- LTBR N/A
- HRTX 1987
- Fundamental
- Price
- LTBR $15.13
- HRTX $1.35
- Analyst Decision
- LTBR
- HRTX Strong Buy
- Analyst Count
- LTBR 0
- HRTX 2
- Target Price
- LTBR N/A
- HRTX $4.50
- AVG Volume (30 Days)
- LTBR 1.5M
- HRTX 2.6M
- Earning Date
- LTBR 08-11-2025
- HRTX 08-08-2025
- Dividend Yield
- LTBR N/A
- HRTX N/A
- EPS Growth
- LTBR N/A
- HRTX N/A
- EPS
- LTBR N/A
- HRTX N/A
- Revenue
- LTBR N/A
- HRTX $149,694,000.00
- Revenue This Year
- LTBR N/A
- HRTX $10.62
- Revenue Next Year
- LTBR N/A
- HRTX $12.99
- P/E Ratio
- LTBR N/A
- HRTX N/A
- Revenue Growth
- LTBR N/A
- HRTX 9.78
- 52 Week Low
- LTBR $2.24
- HRTX $1.04
- 52 Week High
- LTBR $18.80
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- LTBR 52.17
- HRTX 36.48
- Support Level
- LTBR $12.93
- HRTX $1.33
- Resistance Level
- LTBR $16.19
- HRTX $1.43
- Average True Range (ATR)
- LTBR 1.48
- HRTX 0.07
- MACD
- LTBR -0.02
- HRTX 0.02
- Stochastic Oscillator
- LTBR 37.48
- HRTX 45.45
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.